Bronchodilator, vasodilator and spasmolytic activities of Cymbopogon martinii

Journal of Physiology and Pharmacology

Volumn 65, Issue 6, 2014, Pages 859-866

  Janbaz, K H ^a   Qayyum, A ^a   Saqib, F ^a   Imran, I ^a   Zia Ul Haq, M ^b   De Feo, Vincenzo ^c  

^a BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

^b The Patent Office   (Pakistan)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

Bronchodilator effect; Calcium; Cymbopogon martinii; Oxidative stress; Spasmolytic effect; Vasorelaxant effect

Indexed keywords

CYMBOPOGON MARTINII EXTRACT; PHENYLEPHRINE; PLANT EXTRACT; UNCLASSIFIED DRUG; VERAPAMIL; BRONCHODILATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHODILATATION; CALCIUM SIGNALING; CONCENTRATION RESPONSE; CONTROLLED STUDY; EC50; FEMALE; MALE; MUSCLE RELAXATION; PLANT LEAF; RABBIT; SPASMOLYSIS; VASODILATATION; ANIMAL; CYMBOPOGON; DRUG EFFECTS; IN VITRO STUDY; JEJUNUM; PHYSIOLOGY; THORACIC AORTA; TRACHEA;

ANIMALS; AORTA, THORACIC; BRONCHODILATOR AGENTS; CALCIUM CHANNEL BLOCKERS; CYMBOPOGON; FEMALE; IN VITRO TECHNIQUES; JEJUNUM; MALE; PARASYMPATHOLYTICS; PLANT EXTRACTS; PLANT LEAVES; RABBITS; TRACHEA; VASODILATOR AGENTS; VERAPAMIL;

EID: 84919955526     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Cope TA. Poaceae: Flora of Pakistan. Karachi, Pakistan, University of Karachi, 1982.
2. Rao BR, Rajput DK, Patel RP. Essential oil profiles of different parts of Palmarosa (Cymbopogon martinii (Roxb.) Wats. var. motia Burk.). J Essent Oil Res 2009; 21: 519-521.
3. Rao BR, Rajput DK, Patel RP, Purnanand S. Essential oil yield and chemical composition changes during leaf ontogeny of palmarosa (Cymbopogon martinii var. motia). Nat Prod Commun 2010; 5: 1947-1950.
4. Siddiqui N, Garg SC. Chemical composition of Cymbopogon martinii (Roxb.) Wats. var. martinii. J Essent Oil Res 1990; 2: 93-94.
5. D'Souza AM, Paknikar SK, Dev V, Beauchamp PS, Kamat SP. Biogenetic-type synthesis of (+)-cymbodiacetal, a constituent of Cymbopogon martinii. J Nat Prod 2004; 67: 700-702.
6. Bottini AT, Dev V, Garfagnoli DJ, Hope H, Joshi P, Lohani H. Isolation and crystal structure of a novel dihemiacetal bismonoterpenoid from Cymbopogon martinii. Phytochemistry 1987; 26: 2301-2302.
7. Dubey VS, Luthra R. Biotransformation of geranyl acetate to geraniol during palmarosa (Cymbopogon martini Roxb. Wats. var. motia) inflorescence development. Phytochemistry 2001; 57: 675-680.
8. Burkill HM. The Useful Plants of West Tropical Africa, London, UK, Royal Botanic Gardens; 1985.
9. Boulos L. Medicinal Plants of North Africa. Indiana University, 1983.
10. Duke JA, DuCellier JL. Duke's Handbook of Medicinal Plants of the Bible. Boca Raton, CRC Press, 2008.
11. Kumaran AM, D'Souza P, Agarwal A, Bokkolla RM, Balasubramaniam M. Geraniol, the putative anthelmintic principle of Cymbopogon martinii. Phytother Res 2003; 17: 957.
12. Katiki LM, Chagas AC, Bizzo HR, Ferreira JF, Amarante AF. Anthelmintic activity of Cymbopogon martinii, Cymbopogon schoenanthus and Mentha piperita essential oils evaluated in four different in vitro tests. Vet Parasitol 2011; 183: 103-108.
13. Prashar A, Hili P, Veness RG, Evans CS. Antimicrobial action of palmarosa oil (Cymbopogon martinii) on Saccharomyces cerevisiae. Phytochemistry 2003; 63: 569-675.
14. Prasad CS, Shukla R, Kumar A, Dubey NK. In vitro and in vivo antifungal activity of essential oils of Cymbopogon martini and Chenopodium ambrosioides and their synergism against dermatophytes. Mycoses 2010; 53: 123-129.
15. Tyagi BK, Shahi AK, Kaul BL. Evaluation of repellent activities of Cymbopogon essential oils against mosquito vectors of malaria, filariasis and dengue fever in India. Phytomedicine 1998; 5: 324-329.
16. Das MK, Ansari MA. Evaluation of repellent action of Cymbopogan martinii Stapf. var sofia oil against Anopheles sundaicus in tribal villages of Car Nicobar Island, Andaman and Nicobar Islands, India. J Vector Borne Dis 2003; 40:100-104.
17. Gacche RN, Shaikh RU, Chapole SM, Jadhav AD, Jadhav SG. Kinetics of inhibition of monoamine oxidase using Cymbopogon martinii (Roxb.) Wats.: a potential antidepressant herbal ingredient with antioxidant activity. Indian J Clin Biochem 2011; 26: 303-308.
18. Tamuli P, Saikia M, Boruah P. Post-infectional biochemical changes in Cymbopogon martinii (Roxb.) Wats and Cymbopogon citratus (DC) Stapf. due to leaf rust disease. Am J Plant Sci 2013; 4: 1666-1668.
19. Ghadyale V, Takalikar S, Haldavnekar V, Arvindekar A. Effective control of postprandial glucose level through inhibition of intestinal alpha glucosidase by Cymbopogon martinii (Roxb.). Evid Based Complement Altern Med 2012; 2012: 372909.
20. Buch P, Patel V, Ranpariya V, Sheth N, Parmar S. Neuroprotective activity of Cymbopogon martinii against cerebral ischemia/reperfusion-induced oxidative stress in rats. J Ethnopharmacol 2012; 142: 35-40.
21. Khare CP. Indian Medicinal Plants an Illustrated Dictionary. Springer, 2007.
22. Zia-Ul-Haq M, Riaz M, De Feo V, Jaafar HZ, Moga M. Rubus fruticosus L.: constituents, biological activities and health related uses. Molecules 2014; 19: 10998-11029.
23. Zia-Ul-Haq M, Ahmad S, Bukhari SA, Amarowicz R, Ercisli S, Jaafar HZ. Compositional studies and biological activities of some mash bean (Vigna mungo (L.) Hepper) cultivars commonly consumed in Pakistan. Biol Res 2014; 47: 23.
24. Zia-Ul-Haq M, Stankovic M, Rizwan K, De Feo V. Grewia asiatica L., a food plant with multiple uses. Molecules 2013; 18: 2663-2682.
25. Guide for the Care and Use of Laboratory Animals. National Research Council. Washington DC, National Academy Press, 2011.
26. Raina VK, Srivastava SK, Aggarwal KK, Syamasundar KV, Khanuja SP. Essential oil composition of Cymbopogon martinii from different places in India. Flavour Fragr J 2003; 18: 312-315.
27. Devi RC, Sim SM, Ismail R. Spasmolytic effect of citral and extracts of Cymbopogon citratus on isolated rabbit ileum. J Smooth Muscle Res 2011; 47: 143-156.
28. de Menezes-Filho JE, Gondim AN, Cruz JS, et al. Geraniol blocks calcium and potassium channels in the mammalian myocardium: useful effects to treat arrhythmias. Basic Clin Pharmacol Toxicol 2014; 115: 534-544.
29. Gilani AH, Shah AJ, Ghayur MN, Majeed K. Pharmacological basis for the use of turmeric in gastrointestinal and respiratory disorders. Life Sci 2005; 76: 3089-3105.
30. Imran I, Hussain L, Zia-Ul-Haq M, Janbaz KH, Gilani AH, De Feo V. Gastrointestial and respiratory activities of Acacia leucophloea. J Ethnopharmacol 2011; 138: 676-682.
31. Kitic D, Brankovic S, Radenkovic M, Savikin K, Zdunic G, Kocic B, Velickovic-Radovanovic R. Hypotensive, vasorelaxant and cardiodepressant activities of the ethanol extract of Sideritis raeseri spp. raeseri Boiss & Heldr. J Physiol Pharmacol 2012; 63: 531-535.
32. Farre AJ, Colombo M, Fort M, Gutierrez B. Differential effects of various Ca2+ antagonists. Gen Pharmacol 1991; 22: 177-181.
33. Van Rossum JM. Cumulative dose-response curves. II. Technique for the making of dose response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther 1963; 143: 299-330.
34. Janbaz KH, Haider S, Imran I, Zia-Ul-Haq M, De Martino L, De Feo V. Pharmacological evaluation of Prosopis cineraria (L.) Druce in gastrointestinal, respiratory, and vascular disorders. Evid Based Complement Alternat Med 2012; 2012: 735653.
35. Chaudhary MA, Imran I, Bashir S, Mehmood MH, Rehman NU, Gilani AH. Evaluation of gut modulatory and bronchodilator activities of Amaranthus spinosus Linn. BMC Complement Altern Med 2012; 12: 166.
36. Ghayur MN, Gilani AH. Studies on cardio-suppressant, vasodilator and tracheal relaxant effects of Sarcococca saligna. Arch Pharm Res 2006; 29: 990-997.
37. Karaki H, Ozaki H, Hori M, et al. Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev 1997; 49: 157-230.
38. Godfraind T, Miller R, Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol Rev 1986; 38: 321-416.
39. Brading AF. How do drugs initiate contraction in smooth muscles? Trends Pharmacol Sci 1981; 2: 261-265.
40. Fleckenstein A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol 1977; 17: 149-166.
41. Felder CC. Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J 1995; 9: 619-625.
42. Pang S, Tsuchiya S, Horie S, Uchida M, Murayama T, Watanabe K. Enhancement of phenylephrine-induced contraction in the isolated rat aorta with endothelium by H2O-extract from an Oriental medicinal plant Leonuri herba. Jpn J Pharmacol 2001; 86: 215-222.
43. Gurney AM. Mechanisms of drug-induced vasodilation. J Pharm Pharmacol 1994; 46: 242-251.
44. Ghayur MN, Gilani AH, Ahmed T, et al. Muscarinic, Ca++ antagonist and specific butyrylcholinesterase inhibitory activity of dried ginger extract might explain its use in dementia. J Pharm Pharmacol 2008; 60: 1375-1383.
45. Su XH, Duan R, Sun YY, et al. Cardiovascular effects of ethanol extract of Rubus chingii Hu (Rosaceae) in rats: an in vivo and in vitro approach. J Physiol Pharmacol 2014; 65: 417-424.